
The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @IDSAinfo
Joined February 2022
- Tweets3.9K
- Following10
- Followers23K
- Likes393
Hypoalbuminemia and Pharmacokinetics: Revisiting Fundamental Principles and Clinical Perspectives
β
Just Accepted
π bit.ly/47BCXUx
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
β
Just Accepted
bit.ly/4kcLjcx
Antibiotic Stewardship, Resistance, and Mortality in Vancomycin-Resistant Enterococcus: A Quasi-Experimental Study of Linezolid Restrictions
β
Just Accepted
β Editor's Choice
π bit.ly/4BcHhqZ
The Piperacillin-Tazobactam MIC Behaves Like a Prognostic Marker, Not a Pharmacodynamic Exposure
β
Just Accepted
π bit.ly/4zKnrSg
The piperacillin-tazobactam is behaving like a prognostic factor, but that does not negate the pharmacodynamic hypothesis
β
Just Accepted
π bit.ly/3VXonUL
HIV and Cancer Progression: Interpreting Real-World Evidence
β
Just Accepted
π bit.ly/47vVAZW
Randomized Trial Comparing Minocycline-EDTA-Ethanol Lock to Standard-of-Care Antibiotic Lock for Management of Central LineβAssociated Bloodstream Infection
β
Just Accepted
π bit.ly/4yUq7wp
Estimating Cancer Progression Risk by HIV Status: Design and Interpretation of Real-World Comparisons
β
Just Accepted
π bit.ly/4BceqTl
Drug plasmatic level determination in malaria late treatment failures supports CDC recommendation for extending the duration of artemether-lumefantrine treatment
β
Just Accepted
π bit.ly/4i5tZUe
Outpatient Antibiotic Fills and 30-Day Readmission Following Patient-Directed Discharge in Drug Use-Associated Infective Endocarditis in a National Medicaid Cohort
β
Just Accepted
βοΈ @fionagispen and @wcmid
bit.ly/4s7z8Qc
Leaving With Medical Advice: Why Prescribing Antibiotics to People with Endocarditis Who Leave the Hospital Early Makes Sense
β
Just Accepted
π bit.ly/4yoKZuY
Risk Factors and Therapeutic Consequences of Virologic Failure With Long-Acting Cabotegravir Plus Rilpivirine in the DatβAIDS Cohort
β
Just Accepted
β Editor's Choice
π bit.ly/4jWMUTJ
Does Low Baseline RPR Reflect Treatment Failure or Serologic Response Dynamics in Syphilis Among People With HIV?
β
Just Accepted
π bit.ly/4yKU8Pf
Low Baseline RPR Titers and Serological Response: Persistent Questions Among People with HIV
β
Just Accepted
π bit.ly/4zxAZAk
Waterborne outbreak of Mycobacterium abscessus in a UK specialist heart and lung hospital 2019-2026: patients, mitigations and implications
π Repost
π bit.ly/4jHjZCW
Antimicrobials in a Box: A Primer on the Risks of Direct-to-Consumer Antimicrobial Preparedness Kits
π Repost
βοΈ @weskufel
π bit.ly/4iRNtOi
Excess Hospital Use and Years of Life Lost After Cancer Diagnosis among People with HIV: A Nationwide Study in Spain
β
Just Accepted
βοΈ @CesseiE @MinfecciosasUMH @CinfecciosasUMH
π bit.ly/4s1YKOB
Antibiotic exposure and the emergence of multidrug resistant bacteria in patients with liver cirrhosis: A prospective cohort study
β
Just Accepted
π bit.ly/4j9YlqW
Shorter Antibiotic Duration for Pseudomonas Bacteremia: A Call for Future Trials
β
Just Accepted
βοΈ @arthur_alb1
bit.ly/4yKKBYL
Tipping the Scales: More Reasons to Re-evaluate Antibiotic Use in Patients with Advanced Liver Disease
β
Just Accepted
π bit.ly/4zw7j6V

ALT Excerpt from IDSA discussing the complexity of antibiotic decision-making in advanced chronic liver disease patients. It highlights challenges due to infections, decompensation, and multidrug-resistant organisms, noting increased mortality and difficulty in differentiating infection from other causes.















